Aurobindo Pharma Subsidiaries Secure FDA, Health Canada, and EU Biosimilar Approvals and Partnerships
Aurobindo Pharma's subsidiaries secured Health Canada approval for bevacizumab biosimilar Bevqolva, an EU distribution deal with STADA for two EMA-approved biosimilars, and US FDA approval for ADQUEY ointment for atopic dermatitis.